The investment decision files submitted by CDC International Capital to its governance body (members of CDC International Capital which have RI accountability are part of this governance) is always supported by a compliance note which incorporates the ESG issues and factors as well as all the complete due diligence to fulfil its obligations and management of risk regarding anti-money laundering and counter-terrorist financing.
The 2017 new ESG process integrated in the overall investment process states that, for each investment case, a synthesis of the ESG due diligence will be formalised within the “Secretary General’s note” (pre-aquisition stage).
When the transaction value is above a certain amount and has a strong risk, a specific committee including some members of Caisse des Depots (parent company of CDC International Capital) ask for another ESG review and benchmark the CDC International Capital transaction in order to enlighten its own investment decision.
- Investments analysts and portfolio managers are committed to applying ESG requirements (formalised within the investment process) in all the investment stages.
- The Chief Compliance Officer (CCO): he guarantees the overall consistency of the IR approach and ensures the proper application of ESG requirements ill all the investment stages.
- An external service provider helps CDC IC to implement its IR process by providing CDC IC, if necessary, with materials regarding ESG issues of a targeted investment (ESG risks regarding implementation countries and business activity, ESG issues regarding the Company’s profile, etc.).
- CDC Group requests to CDC IC an annual CSR reporting as well an SRI annual reporting.